In summary, may we conclude that adding vimentin to an immunopanel consisted of basal cytokeratins (CK5/6, 14, 17) appears to be inefficient at predicting survival of triple negative breast cancer patients. Here, KRT5 is linked to triple-negative breast carcinoma.